EMD-17295

Single-particle
3.8 Å
EMD-17295 Deposition: 05/05/2023
Map released: 03/07/2024
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-17295

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8oyt summary report (pdf.gz) Map-8oyt FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Stabilised BA.1 SARS-CoV-2 spike with H6 nanobodies in '3 up' RBD conformation

EMD-17295

Single-particle
3.8 Å
EMD-17295 Deposition: 05/05/2023
Map released: 03/07/2024
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4
Sample: Complex of stabilised HexaPro Omicron BA.1 spike trimer with three H6 nanobodies
Fitted models: 8oyt

Deposition Authors: Weckener M, Naismith JH, Owens RJ
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.
PUBMED: 38835241
DOI: doi:10.1098/rsob.230252
ISSN: 2046-2441
Grant Support: